XPEL, INC.

XPEL

CIK 0001767258 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$122M
↑+13.7% +$15Mvs FY2024 (Q4)
Operating Income
$15M
↑+25.4% +$3Mvs FY2024 (Q4)
Net Income
$13M
↑+50.7% +$5Mvs FY2024 (Q4)
Gross Profit
$51M
↑+17.1% +$7Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
78/100
  • Profitability
    75ROIC 20.0% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.25 (above 1.5 = solid)
  • Leverage
    100D/E 0.01 (under 0.5 = conservative)
  • Efficiency
    94Asset Turnover 1.43x (1.0+ = capital-efficient)
  • Growth
    62Revenue YoY +13.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    36Op Margin 12.7% · trend -0.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project XPEL's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 148.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$75.82
Total enterprise IV
$2.10B
Diluted shares
0.03B
Terminal PV
$1.63B (78% of total)
Year-5 FCF
$192M
YearProjected FCFDiscounted PV
+1$79M$72M
+2$98M$81M
+3$123M$92M
+4$154M$105M
+5$192M$119M
Terminal$2.62B$1.63B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$4M
investment in PP&E
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$383M
everything owned
Total liabilities
$97M
everything owed
Stockholders' equity
$280M
shareholder claim
Net debt
$-50M
Net cash position ($50M)

Recent performance · 31 quarters

Revenue↑+13.7% +$15M
$122M
Net Income↑+50.7% +$5M
$13M
Free Cash Flow↓-66.1% -$3M
$2M
Operating Margin↑+1.2pts
12.7%

Drill down